Biotech Startups
9,911 companies tagged Biotech, with their investors and founders.
Abbelight provides microscopy equipment, reagents, and services to researchers and biotech labs for studying biology at the molecular level. The company develops bioimaging platforms intended to support advanced diagnostics and therapeutics.
2 investors
AbCellera develops antibody-based medicines using a technology platform that integrates biology, computation, and engineering, working with pharmaceutical partners on antibody drug programs including bispecifics and antibody drug conjugates. The company operates in the biotech and drug discovery sector, focusing on first-in-class and best-in-class antibody therapeutics for complex targets such as transmembrane proteins.
2 investors
AbilityPharma develops innovative oncology therapies that induce autophagy to treat various cancers and address unmet medical needs. The company has advanced therapies including ibrilatazar (ABTL0812) through clinical trials for lung cancer, pancreatic cancer, and other tumor types.
2 investors
ABK Biomedical is a clinical-stage medical device company that develops x-ray visible glass microspheres for Y-90 radioembolization and embolic treatment of cancers such as liver cancer. Spun out of Dalhousie University, it serves interventional oncology and radiology applications.
2 investors
ABL Bio develops biotherapeutic drugs using dual antibody platform technology for immunotherapy cancer treatments and degenerative neurological diseases. The company is a South Korea-based biotech research firm with proprietary platforms designed to treat intractable diseases.
2 investors
Abselion develops measurement tools and a platform combining hardware, purpose-built assay formats, and software for biological measurements such as protein quantification. It serves scientists and researchers across life sciences, biotech, and therapeutic development.
2 investors
Absolute Foods is an agricultural biotechnology company working on bioscience-based approaches to farming and sustainability. The page references work in gene editing, agrobacterium biology, and biological crop protection, positioning the company in the ag-tech and bio-innovation space with a stated focus on building a global company from India.
2 investors
Access Vascular develops thrombus-evading intravascular catheters made from a proprietary biomaterial, offering an FDA-cleared PICC and the HydroMID peripherally inserted midline catheter to reduce vascular access complications. The company designs and manufactures its medical devices for clinical use in the United States.
2 investors
Accuitis is developing a lead drug compound that restores mitochondrial SIRT3 expression to recover healthy cellular function, targeting neurodegenerative diseases including Alzheimer's, Parkinson's, and methamphetamine addiction. Its work is in preclinical research and development.
2 investors
Accure Health is a company focused on developing treatments to improve the lives of patients and their relatives affected by central nervous system (CNS) diseases. It operates in the biotech sector.
2 investors
US biotech using AI-driven computational design plus wet-lab validation to discover small-molecule oncology drugs.
2 investors
Achieve Life Sciences is a late-stage specialty pharmaceutical company developing cytisinicline, a treatment for nicotine dependence and smoking cessation. It is pursuing FDA approval for the drug as a new option for people trying to quit smoking or vaping in the US.
2 investors
Achira builds molecular world models that blend geometric deep learning, physics, and quantum chemistry to advance drug discovery and materials design. The company combines AI and physical simulation to enable out-of-sample prediction for biomolecular applications.
2 investors
Aclid provides an automation platform for biosecurity and biosafety compliance, offering real-time screening that generates threat assessments and risk profiles for genes, libraries, pools, viral vectors, and plasmids. It also automates verification of licenses, registrations, biosafety guidelines, and legitimate use for research organizations.
2 investors
Acousia Therapeutics develops small-molecule drug candidates with a dual mode of action for treating acute and chronic sensorineural hearing loss (SNHL), targeting outer hair cells in the inner ear to preserve and enhance natural hearing. The biotech company focuses on drug therapies as a first-line or complementary option to hearing aids and cochlear implants.
2 investors
Acoustica.bio develops acoustophoretic technology and microgel suspension formulations that concentrate biologic drugs (such as monoclonal antibodies) to ultra-high concentrations exceeding 500 mg/mL for small-volume subcutaneous injection. It serves drug developers, aiming to convert hospital-based intravenous therapies into patient-friendly at-home injections in the biotech/drug delivery space.
2 investors
ACT Genomics is a cancer genomics company that provides genomic testing solutions to support personalized cancer care and precision medicine for patients and clinicians. Founded in 2014 as a member of the Delta Group, it focuses on the Taiwanese and broader Asian markets.
2 investors
Acticor Biotech develops Glenzocimab, a therapeutic candidate targeting GPVI for treating acute ischemic stroke and STEMI. The company is focused on cardiovascular and cerebrovascular indications.
2 investors
Actio is a precision medicine company that translates genetic insights into new therapeutics, developing drugs that target the genes underlying both rare diseases and more prevalent conditions. It focuses on identifying dysregulated gene activity and designing therapies to restore balance and address the root causes of disease.
2 investors
Clinical-stage therapeutics company focusing on high-impact cancers and inflammatory diseases.
2 investors
2 investors
A pharmaceutical company focused on supplying medicines and improving access to high-quality drugs, offering branded originator drugs, authorized generics, complex generics, and other generic medicines. It operates globally with expertise in science, medical, and manufacturing, and this page covers its Japan product offerings.
2 investors
Cascade is an AI coordination platform for architecture, engineering, and construction firms that automates business development by analyzing unstructured project opportunities, scoring them for firm fit, and streamlining the pursuit-to-delivery cycle. The platform learns from each customer interaction to improve recommendations and turns the construction industry's relationship-driven sales process into a systematic, data-driven approach.
2 investors
A biopharmaceutical company with over 30 years of experience developing and commercializing treatments for central nervous system (CNS) diseases. It maintains a pipeline of product candidates supported by internal research and development.
2 investors